Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer

BACKGROUND: Prostate cancer (PCa), the second most common cancer affecting men worldwide, shows a broad spectrum of biological and clinical behaviour representing the epiphenomenon of an extreme heterogeneity. Androgen deprivation therapy is the mainstay of treatment for advanced forms but after few...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cell Commun Signal
Egile Nagusiak: Ferrari, Nicoletta, Granata, Ilaria, Capaia, Matteo, Piccirillo, Marina, Guarracino, Mario Rosario, Venè, Roberta, Brizzolara, Antonella, Petretto, Andrea, Inglese, Elvira, Morini, Martina, Astigiano, Simonetta, Amaro, Adriana Agnese, Boccardo, Francesco, Balbi, Cecilia, Barboro, Paola
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2017
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5721601/
https://ncbi.nlm.nih.gov/pubmed/29216878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12964-017-0206-x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak